Skip to content

Quick ratio at other companies

Emergent Biosolutions logo
Emergent BiosolutionsEBS
2.1×-1.4×
Opko Health logo
Opko HealthOPK
3.2×+0.9×
Merck & Co. logo
Merck & Co.MRK
1.1×-0.2×
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
+0.6×
Septerna, Inc. logo
Septerna, Inc.SEPN
4.7×-27.5×
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
32.6×+16.8×

Other financials

Income statement

See full
Revenue$6.2M-11.3%
Gross profit$3.3M-52.0%
Operating income-$5.3M-136%
Net income-$3.5M-746%
EPS (diluted)-$0.05-400%

Balance sheet

See full
Cash & equivalents$145.6M-10.3%
Total debt$601.0K-50.6%
Total equity$151.6M-29.8%
Total assets$219.4M-11.2%

Cash flow

See full
Operating cash flow-$8.7M-223%
CapEx--100%
Free cash flow-$8.7M-223%

Valuation

See full
Market cap$261.08M-44.3%
Enterprise value$116.11M-59.6%
P/E10.3×+3.8×
P/S2.8×+0.2×

Profitability

See full
Gross margin65.4%-11.2pp
Operating margin52.4%-7.8pp
Net margin43.2%-6.1pp
FCF margin66.2%

Returns & leverage

See full
Return on equity39.9%-18.5pp
Debt / equity0.0×
Current ratio3.2×-5.2×

Where this comes from

Calculated from SIGA Technologies’s reported figures.

Based on the most recent quarter.

The official record: SIGA Technologies’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about SIGA Technologies's quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SIGA Technologies's quick ratio?
SIGA Technologies (SIGA) reported quick ratio of 2.4× in Q1 2026.
How has SIGA Technologies's quick ratio changed year-over-year?
SIGA Technologies's quick ratio decreased by 62.1% year-over-year, from 6.3× to 2.4×.
What is the long-term trend for SIGA Technologies's quick ratio?
Over 5 years (2020 to 2025), SIGA Technologies's quick ratio has grown at a -5.0% compound annual growth rate (CAGR), from 11.8× to 9.1×.
What does quick ratio mean?
Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.